Bausch+Stroebel

Name

Bausch+Stroebel

Legal name

Bausch+Ströbel SE + Co. KG

Website

https://bausch-stroebel.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Filling and Packaging Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG)

akta.pro secondary industry

High-Potency API (HPAPI) Development & Manufacturing (HLAGAHAC)

Keywords

• Pharmaceutical filling machines
• Aseptic packaging equipment
• Containment systems
• RTU syringe processing
• HPAPI manufacturing solutions

Headquarters

HQ city

Ilshofen

HQ country

Germany

HQ region

Europe

Offices13 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Equipment Sales: Sale of filling, packaging, and containment machines for pharmaceutical production. Equipment includes RTU platforms, bulk platforms, flexible production platforms, and secondary packaging solutions. One-time capital equipment purchases with long sales cycles and custom configuration.
2. Aftermarket Services and Spare Parts: Lifecycle services including maintenance, calibration, qualification, and spare parts supply. Services include Availability, Performance, Empowerment, and Pharma Reliability offerings to ensure maximum equipment performance throughout operational life.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Bausch+Stroebel designs, manufactures, and sells aseptic filling, packaging, and containment machines for the pharmaceutical industry. Its portfolio covers ready-to-use (RTU) syringe, vial, and cartridge platforms, bulk platforms, flexible production systems (VarioSys, CombiSys, GENEX), secondary packaging solutions, and high-containment systems for HPAPIs, complemented by LifeCycle Services for installation, qualification, maintenance, calibration, and spare parts.

Product overview

Bausch+Stroebel is a leading manufacturer of pharmaceutical filling and packaging equipment offering an integrated portfolio of solutions. The core product line includes RTU Platforms for processing ready-to-use syringes, vials, and cartridges, and Bulk Platforms for handling containers in bulk format. The Flexible Production Platforms enable processing of different container types on a single system. Secondary Packaging Solutions handle post-fill operations including labeling and assembly. Containment Systems provide protection for highly potent active pharmaceutical ingredients (HPAPIs). The portfolio includes specialized products like GENEX for aseptic small batch production of ADCs and ATMPs, and FVF 5063 for commercial-scale HPAPI vial filling at up to 24,000 vials per hour. The VarioSys® and CombiSys systems provide flexible production capabilities. Services include LifeCycle Services for equipment performance optimization and Pharma Reliability Services for calibration, aseptic support, and regulatory compliance.

Differentiator

Problem solved

Functional benefit

Brands

• VarioSys: Innovative flexible production system for pharmaceutical manufacturing
• CombiSys
• GENEX
• AdvancedFill
• FVF 5063

Products and services

• RTU Platforms Solutions for filling and closing ready-to-use (RTU) syringes, vials, and cartridges. These platforms process pre-sterilized containers for aseptic pharmaceutical filling operations and are intended for pharmaceutical manufacturers requiring high-throughput, sterile injectable processing.
• Bulk Platforms Solutions for filling and closing vials and cartridges in bulk format. These platforms handle containers that require on-site sterilization and preparation prior to filling, intended for pharmaceutical manufacturers using bulk container processing workflows.
• Flexible Production Platforms Flexible and scalable solutions for processing different container types on a single platform. These systems offer versatility for varying production requirements and batch sizes and are designed for pharmaceutical manufacturers needing to run multiple container formats on one line.
• Secondary Packaging Solutions Solutions for safe handling, labeling, and assembly of syringes, vials, and cartridges. These systems handle post-fill processing including final packaging operations for pharmaceutical manufacturers.
• Containment Systems Specialized containment solutions for safe handling of highly potent active pharmaceutical ingredients (HPAPIs). These systems protect operators and the environment during aseptic processing of hazardous compounds and are intended for pharmaceutical manufacturers handling high-potency compounds.
• Integrated Solutions Integrated solutions combining filling, packaging, and containment capabilities for comprehensive pharmaceutical production. These systems provide seamless production workflows with coordinated equipment and processes for pharmaceutical manufacturers seeking end-to-end production lines.
• GENEX Fully automatic filling and packaging system designed for aseptic small batch production of Antibody-Drug Conjugates (ADCs) and Advanced Therapy Medicinal Products (ATMPs). Designed for maximum sterility at minimal batch sizes with high product value, targeting biotech manufacturers of novel therapies.
• FVF 5063 Commercial-scale vial filling and closing machine for HPAPI processing. Capable of up to 24,000 vials per hour with 100% in-process control and minimal product loss. Features AdvancedFill technology for reduced startup/shutdown product waste and modular dosing systems including peristaltic pumps and time-pressure systems, intended for high-throughput HPAPI commercial manufacturing.
• VarioSys Innovative flexible production system introduced in 2014, enabling extremely flexible drug manufacturing for pharmaceutical and biotech industries. The system allows processing of different container types and formats on the same equipment.
• CombiSys Flexible system solution introduced in 2020, providing integrated capabilities for pharmaceutical production workflows.
• Pharma Reliability Services Services for reliable pharmaceutical production including calibration, aseptic support, and process optimization. Provides reliable measurement documentation, controlled process conditions, and audit/GMP compliance support for operators of Bausch+Ströbel equipment.
• LifeCycle Services Comprehensive lifecycle services accompanying customers through all phases of pharmaceutical production for maximum equipment performance, highest availability, and sustainable success throughout the entire product lifecycle. Includes Availability, Performance, Empowerment, and Pharma Reliability offerings covering maintenance, calibration, qualification, and spare parts supply.

Quantifiable outcome

• Up to 24,000 vials per hour processing speed
• +3 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Two partnerships are on record, tiered core.

• Wilco AGcoreStrategic or Co-development Partner · 1 January 2012Swiss subsidiary acquired in 2012, expanding the company's presence in the Swiss market and strengthening the group's international network.
• KyoobeTechcoreStrategic or Co-development PartnerTechnology company subsidiary based in Germany, part of the worldwide Bausch+Ströbel network.

Scale indicators8 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• GEA Group: Large German industrial conglomerate with a pharmaceutical equipment division offering separation, homogenization, and filling technologies. Less focused on primary container filling than Bausch+Ströbel but overlaps in sterile processing and aseptic manufacturing solutions.
• Stevanato Group: Italian-based supplier of pharmaceutical glass containers and integrated drug delivery systems. Broader scope than Bausch+Ströbel but competes in the fill-finish ecosystem, particularly serving biologics manufacturers with combined containment, glass, and processing solutions.

Direct peers

• Körber Pharma: German technology group providing packaging and processing solutions for pharmaceuticals. Competes directly with Bausch+Ströbel in blister packaging, vial processing, and integrated production lines for solid and parenteral dosage forms.
• Syntegon Technology: Formerly Bosch Packaging Technology, Syntegon is a direct competitor in pharmaceutical filling and packaging machinery. The two companies compete head-to-head on aseptic filling lines for vials, syringes, and ampoules serving the same pharmaceutical manufacturer customer base globally.
• Optima Group: German family-owned Optima manufactures filling and packaging machinery for pharmaceuticals, cosmetics, and consumer goods. Direct overlap with Bausch+Ströbel in aseptic liquid filling, vial/syringe processing, and containment systems for HPAPIs.
• Romaco Group: European pharmaceutical processing and packaging equipment manufacturer owned by Truffle Capital. Direct competitor in tablet coating, granulation, and sterile filling machinery, serving similar pharmaceutical manufacturer customers as Bausch+Ströbel.
• Marchesini Group: Italian manufacturer of packaging machinery serving pharmaceutical and cosmetics industries. Competes with Bausch+Ströbel in secondary packaging, vial/syringe handling, and integrated aseptic processing lines.
• IMA Group: Italian-headquartered IMA is a leading manufacturer of packaging machinery for pharmaceuticals, cosmetics, and food. Its pharmaceutical division competes directly with Bausch+Ströbel in aseptic filling and packaging equipment, particularly for sterile injectable products.

Emerging players

• West Pharmaceutical Services: US-headquartered manufacturer of pharmaceutical elastomer components and delivery systems. While primarily a components supplier rather than equipment maker, West increasingly offers integrated containment and fill-finish solutions overlapping with Bausch+Ströbel's containment and HPAPI capabilities.

Others

• Catalent: Major CDMO providing drug development and manufacturing services. While a customer/user of fill-finish equipment rather than a direct competitor, Catalent's scale in biologics fill-finish services represents both a major customer opportunity and a potential threat if integrated with proprietary processing technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks2 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BauschundStroebel
• LinkedInlinkedin.com/company/767388
• Instagraminstagram.com/bausch_und_stroebel
• YouTubeyoutube.com/@bauschstroebel

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bausch+Stroebel